Radiation that adapts daily: a smarter way to hit tumors and spare organs

NCT ID NCT07687147

Recruiting now Disease control Sponsor: University of Zurich Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial tests a new radiation technique for people with abdominal or pelvic tumors. Standard radiation gives the same dose each session, but this approach adjusts the dose daily based on the exact position of the tumor and nearby organs. The goal is to deliver more radiation to the tumor when it is safely away from sensitive organs, and less when they overlap, potentially improving tumor control without increasing side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MR-guided stereotactic body radiation therapy (SBRT) with adaptive fractionation
What this could lead to: If successful, this approach could allow higher radiation doses to tumors in the abdomen and pelvis while reducing damage to nearby organs, potentially improving treatment outcomes.
What could go wrong: This is a feasibility study with a small number of participants, so results may not apply broadly. The technique is complex and may not be widely adoptable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Abdominal Neoplasms female reproductive organ cancer Pelvic Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ABDOMINAL TUMOR PELVIC TUMOR

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

University Hospital Zurich
RECRUITING

Zurich, Canton of Zurich, 8091, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.